Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linperlisib + Chidamide in R/R CTCL
NCT06037239Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jul 2023
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linperlisib in cutaneous T-cell lymphoma (CTCL), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
linperlisib
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT06037239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06037239.